Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H7ClN4O2 |
InChIKeyYNISPJYJIHXDGM-UHFFFAOYSA-N |
CAS Registry2650350-89-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 27 Apr 2020 |